Search | Page 2 | Aplastic Anemia and MDS International Foundation


Search results

  1. Midostaurin and Azacitidine in Treating Elderly Patients With Acute Myelogenous Leukemia

    ... leukemia [CMML]) will include: hydroxyurea, thalidomide , hematopoietic growth factors, Zarnestra, Lenalidomide , ... of 4 weeks must have elapsed since the administration of thalidomide, Zarnestra, Revlimid, arsenic, SAHA inhibitors, or any ...

    Clinical Trial last updated 06/03/2016 - 2:24pm.

  2. Ruxolitinib Phosphate in Treating Patients With Chronic Neutrophilic Leukemia or Atypical Chronic Myeloid Leukemia

    ... have more long-lasting effects on the marrow, such as thalidomide and its analogs, and interferon, subjects should discontinue ...

    Clinical Trial last updated 06/06/2016 - 2:18pm.

  3. Myelofibrosis (MF)

    ... such as fatigue Immune modulating drugs such as thalidomide and the related drugs lenalidomide and pomalidomide, ...

    Topic section last updated 07/07/2016 - 3:16pm.

  4. Lenalidomide and Rituximab in Subjects With Previously Untreated Indolent Non-Hodgkin's Lymphoma

    ... 28 days of baseline. Known hypersensitivity to thalidomide or rituximab. The development of erythema nodosum if characterized by a desquamating rash while taking thalidomide or similar drugs. Any prior use of lenalidomide. Concurrent ...

    Clinical Trial last updated 06/06/2016 - 10:17am.